A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of the H<sub>3</sub> Receptor Antagonist, GSK239512 as a Monotherapy in Subjects with Mild-to-Moderate Alzheimer’s Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of the H₃ Receptor Antagonist, GSK239512 as a Monotherapy in Subjects with Mild-to-Moderate Alzheimer’s Disease

Published:2014-01-31 Issue:1 Volume:11 Page:47-58
ISSN:1567-2050
Container-title:Current Alzheimer Research
language:en
Short-container-title:CAR

Author:

Grove Richard,Harrington Conn,Mahler Andreas,Beresford Isabel,Maruff Paul,Lowy Martin,Nicholls Andrew,Boardley Rebecca,Berges Alienor,Nathan Pradeep,Horrigan Joseph

Publisher

Bentham Science Publishers Ltd.

Subject

Neurology (clinical),Neurology

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Histamine and Histamine Receptors for Memory Regulation: An Emotional Perspective;Current Neuropharmacology;2024-09

2. Novel measures of cognition and function for the AD spectrum in the Novel Measures for Alzheimer's Disease Prevention Trials (NoMAD) project: Psychometric properties, convergent validation, and contrasts with established measures;Alzheimer's & Dementia;2024-07-04

3. Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer’s Disease, Parkinson’s Disease, and Autism Spectrum Disorder;Pharmaceuticals;2024-06-25

4. Effects of Age and BMI on Histamine H3 Receptor Availability in Healthy Humans;2024-05-15

5. Cognitive impairment among patients with chronic immune thrombocytopenia;British Journal of Haematology;2024-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP